Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rose, M.
Right arrow Articles by Fisher, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rose, M.
Right arrow Articles by Fisher, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2001, Vol. 86, No. 5 678-682
© 2001 The Board of Management and Trustees of the British Journal of Anaesthesia

Rocuronium: high risk for anaphylaxis?

M. Rose1 and M. Fisher1,2

1Royal North Shore Hospital of Sydney, St Leonards, NSW, Australia. 2Department of Anaesthesia, University of Sydney, Sydney, Australia*Corresponding author: Intensive Therapy Unit, Royal North Shore Hospital, Pacific Highway, St Leonards, NSW 2065, Australia

Patients suspected of anaphylaxis during anaesthesia have been referred to the senior author’s clinic since 1974 for investigation. Since release of rocuronium on to the worldwide market, concern has been expressed about its propensity to cause anaphylaxis. We identified 24 patients who met clinical and laboratory (intradermal, mast cell tryptase and morphine radioimmunoassay) criteria for anaphylaxis to rocuronium. The incidence of rocuronium allergy in New South Wales, Australia has risen in parallel with sales, while there has been an associated fall in reactions to other neuromuscular blocking drugs. Data from intradermal testing suggested that rocuronium is intermediate in its propensity to cause allergy in known relaxant reactors compared with low-risk agents (e.g. pancuronium, vecuronium) and higher-risk agents (e.g. alcuronium, succinylcholine).

Br J Anaesth 2001; 86: 678–82


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
P. M. Mertes, A. B. Guttormsen, T. Harboe, S. G. O. Johansson, E. Florvaag, B. Husum, L. H. Garvey, M. Kroigaard, L. Gramstad, K. T. Kvande, et al.
Can Spontaneous Adverse Event Reporting Systems Really Be Used to Compare Rates of Adverse Events Between Drugs?
Anesth. Analg., February 1, 2007; 104(2): 471 - 472.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. M. Bhananker, J. T. O'Donnell, J. R. Salemi, and M. J. Bishop
The Risk of Anaphylactic Reactions to Rocuronium in the United States Is Comparable to That of Vecuronium: An Analysis of Food and Drug Administration Reporting of Adverse Events
Anesth. Analg., September 1, 2005; 101(3): 819 - 822.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
A. D. Axon and J. M. Hunter
Editorial III: Anaphylaxis and anaesthesia--all clear now?
Br. J. Anaesth., October 1, 2004; 93(4): 501 - 504.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
D. L. Hepner and M. C. Castells
Anaphylaxis During the Perioperative Period
Anesth. Analg., November 1, 2003; 97(5): 1381 - 1395.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
C. Baillard, A. M. Korinek, V. Galanton, Y. Le Manach, P. Larmignat, M. Cupa, and C. M. Samama
Anaphylaxis to rocuronium
Br. J. Anaesth., April 1, 2002; 88(4): 600 - 602.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
E. W. Moore and J. M. Hunter
The new neuromuscular blocking agents: do they offer any advantages?
Br. J. Anaesth., December 1, 2001; 87(6): 912 - 925.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.